Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy

Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy

US Patent 10617717 · Granted Apr 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for determining treatment for cancer patients2025
Methods for determining treatment for cancer patients2023
Vascular endothelial growth factor antagonists2022
Predicting optimal chemotherapy for CRC2020
Predicting optimal chemotherapy for CRC2020
OPRT expression and cancer treatment outcome2020
OPRT expression and cancer treatment outcome2020
Quantifying MGMT protein for optimal cancer therapy of glioblastoma2020
Quantifying MGMT protein for optimal cancer therapy of glioblastoma2020
Multiplex MRM assay for evaluation of cancer2020
SRM/MRM assay for the tyrosine-protein kinase receptor UFO(AXL) protein2020
SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein2020